3
Announcements
Trials
Browse
Landscape
Status
Recruiting
3
Not yet recruiting
1
No longer available
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Thoracic Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Neoplasms by Site
1
Neoplasms
1
Lung Neoplasms
1
Lung Diseases
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Bronchogenic
1
Carcinoma
1
Interventions
ceritinib
2
tazemetostat
1
taletrectinib
1
sotorasib
1
rovalpituzumab tesirine
1
rociletinib
1
pegilodecakin
1
patritumab deruxtecan
1
osimertinib
1
lorlatinib
1
dabrafenib
1
capmatinib
1
brigatinib
1
belagenpumatucel L
1
alectinib
1
Suspensions
1
Powders
1
Paclitaxel
1
Nivolumab
1
Crizotinib
1
BID protein, human
1
AM0010
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
taletrectinib
×
Thoracic
×
Clear all
NCT06841874
2025-12-24
Tale EAP
Nuvation Bio Inc.
No longer available